Skip to main content

Patient Support Line 1-800-282-7630 Monday through Friday: 8:00 am – 8:00 pm ET

Image of a father and daughter looking at stars through a telescope. Text on image says “Understanding VIJOICE.”
What is VIJOICE?

VIJOICE is a once-daily, oral medication that is:

The first and only therapy approved to treat PIK3CA-Related Overgrowth Spectrum, or PROS, in children and adults.
A targeted therapy. VIJOICE targets the underlying cause of PROS symptoms, which is a mutation (abnormal change) to the PIK3CA gene. Like other types of targeted therapies, it can also unintentionally affect healthy cells.
A treatment option that has been studied for safety and effectiveness in PROS patients for up to 6 years.

VIJOICE is prescribed for people who:

Is VIJOICE right for me?

You are eligible for VIJOICE if you are 2 years of age or older and have been diagnosed with a severe PROS condition. If you are considering trying new treatment options, ask your doctor about VIJOICE.

What makes VIJOICE different from other therapies?

Other available therapies are used only to manage the symptoms and complications associated with PROS conditions, but they do not treat the root cause of PROS. VIJOICE is the first and only FDA-approved therapy that treats the underlying cause of PROS conditions.